Koninklijke Philips - PHG Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $19.00
  • Forecasted Upside: 24.43 %
  • Number of Analysts: 13
  • Breakdown:
  • 3 Sell Ratings
  • 8 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.28 (1.87%)

This chart shows the closing price for PHG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Koninklijke Philips Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHG

Analyst Price Target is $19.00
▲ +24.43% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Koninklijke Philips in the last 3 months. The average price target is $19.00, with a high forecast of $31.00 and a low forecast of $10.90. The average price target represents a 24.43% upside from the last price of $15.27.

This chart shows the closing price for PHG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 13 investment analysts is to hold stock in Koninklijke Philips. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/1/2022JPMorgan Chase & Co.Lower Target€18.80 ➝ €10.90Low
10/26/2022BarclaysLower Target€38.00 ➝ €19.00Low
10/25/2022HSBCDowngradeHold ➝ ReduceLow
10/18/2022Morgan StanleyInitiated CoverageEqual WeightLow
10/18/2022Jefferies Financial GroupDowngradeBuy ➝ HoldN/A
10/14/2022Deutsche Bank AktiengesellschaftDowngradeHold ➝ SellLow
10/13/2022Societe GeneraleDowngradeBuy ➝ HoldLow
10/13/2022Oddo BhfDowngradeOutperform ➝ Neutral€17.00Low
10/7/2022UBS GroupLower TargetNeutral ➝ Neutral€16.40 ➝ €16.10Low
10/6/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€22.00 ➝ €18.00Low
9/12/2022Societe GeneraleUpgradeHold ➝ Buy€22.40 ➝ €21.00Low
9/5/2022UBS GroupUpgradeSell ➝ NeutralLow
7/28/2022BarclaysLower Target€45.00 ➝ €39.00Low
7/27/2022JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight€21.30 ➝ €18.80Low
7/26/2022UBS GroupLower TargetSell ➝ Sell€17.00 ➝ €16.00Low
7/25/2022Societe GeneraleDowngradeBuy ➝ HoldLow
7/5/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€25.00 ➝ €24.00N/A
7/5/2022BarclaysLower TargetOverweight ➝ Overweight€45.50 ➝ €45.00N/A
6/29/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€30.00 ➝ €25.00Low
6/16/2022UBS GroupDowngradeNeutral ➝ SellLow
5/25/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight€26.50 ➝ €21.30Low
4/26/2022JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral€29.20 ➝ €26.50Low
3/28/2022Credit Suisse GroupLower Target€32.50 ➝ €31.00High
3/28/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€35.00 ➝ €30.00High
1/26/2022Credit Suisse GroupLower TargetNeutral ➝ Neutral€42.00 ➝ €32.50Low
1/21/2022ING GroupDowngradeBuy ➝ HoldLow
1/20/2022Jefferies Financial GroupDowngradeBuy ➝ HoldLow
1/14/2022BarclaysLower Target€51.50 ➝ €46.00High
1/14/2022HSBCUpgradeHold ➝ BuyLow
1/12/2022CitigroupDowngradeBuy ➝ NeutralHigh
1/10/2022Deutsche Bank AktiengesellschaftLower Target€36.00 ➝ €35.00Low
12/1/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
10/27/2021BarclaysReiterated RatingOverweightLow
10/25/2021Credit Suisse GroupReiterated RatingNeutralLow
10/19/2021JPMorgan Chase & Co.Reiterated RatingNeutralHigh
10/19/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldLow
9/10/2021BarclaysReiterated RatingOverweightLow
9/8/2021Jefferies Financial GroupInitiated CoverageBuyLow
8/31/2021ING GroupUpgradeHold ➝ BuyLow
8/4/2021Morgan StanleyReiterated RatingOverweightLow
7/28/2021UBS GroupReiterated RatingBuyLow
7/28/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldLow
7/28/2021Bank of AmericaDowngradeBuy ➝ NeutralLow
7/28/2021Oddo BhfUpgradeNeutral ➝ OutperformLow
7/8/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldLow
6/29/2021BarclaysReiterated RatingOverweightLow
6/21/2021HSBCDowngradeBuy ➝ HoldLow
4/29/2021Berenberg BankReiterated RatingBuyLow
4/28/2021Credit Suisse GroupReiterated RatingNeutralLow
4/27/2021UBS GroupReiterated RatingBuyLow
3/23/2021BarclaysReiterated RatingOverweightMedium
3/18/2021JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
1/26/2021Credit Suisse GroupReiterated RatingNeutralHigh
1/26/2021JPMorgan Chase & Co.Reiterated RatingNeutralHigh
1/26/2021UBS GroupReiterated RatingBuyHigh
1/20/2021Berenberg BankReiterated RatingBuyLow
1/19/2021JPMorgan Chase & Co.Reiterated RatingNeutralLow
11/12/2020Berenberg BankReiterated RatingBuyLow
10/29/2020Morgan StanleyReiterated RatingOverweightLow
10/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
10/20/2020UBS GroupReiterated RatingBuyLow
10/20/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
10/2/2020UBS GroupReiterated RatingBuyLow
9/23/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
9/23/2020BarclaysReiterated RatingOverweightLow
9/3/2020JPMorgan Chase & Co.Reiterated RatingNeutralHigh
9/1/2020UBS GroupReiterated RatingBuyMedium
8/27/2020Societe GeneraleDowngradeSellLow
7/28/2020Societe GeneraleInitiated CoverageBuyMedium
7/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/9/2020Morgan StanleyReiterated RatingOverweightLow
6/22/2020BarclaysReiterated RatingOverweightLow
4/22/2020Morgan StanleyReiterated RatingOverweightLow
4/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralMedium
4/19/2020Kepler Capital MarketsReiterated RatingHoldHigh
4/7/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
3/23/2020DZ BankReiterated RatingHold ➝ BuyHigh
3/23/2020UBS GroupReiterated RatingBuyLow
3/10/2020Kepler Capital MarketsReiterated RatingHoldMedium
2/10/2020UBS GroupReiterated RatingBuyLow
1/21/2020Roth CapitalReiterated RatingBuyMedium
1/13/2020Bank of AmericaBoost TargetBuy$45.00 ➝ $51.00Low
12/6/2019Morgan StanleyUpgradeEqual Weight ➝ OverweightMedium
10/28/2019Berenberg BankReiterated RatingBuyMedium
10/7/2019Berenberg BankReiterated RatingBuyLow
8/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/30/2019CitigroupInitiated CoverageBuy ➝ BuyLow
10/2/2018Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
9/18/2018Exane BNP ParibasUpgradeNeutral ➝ OutperformLow
9/17/2018BNP ParibasUpgradeHold ➝ BuyLow
9/13/2018Sanford C. BernsteinInitiated CoverageOutperformLow
4/17/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
2/12/2018Berenberg BankUpgradeHold ➝ BuyLow
(Data available from 12/4/2017 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 7 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 4 very negative mentions
  • 6 very positive mentions
  • 5 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
  • 7 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
  • 9 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
  • 11 very positive mentions
  • 12 positive mentions
  • 8 negative mentions
  • 5 very negative mentions
  • 5 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 2 very negative mentions

Current Sentiment

  • 5 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Koninklijke Philips logo
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Read More

Today's Range

Now: $15.27
Low: $14.99
High: $15.28

50 Day Range

MA: $14.12
Low: $11.75
High: $16.47

52 Week Range

Now: $15.27
Low: $11.75
High: $38.77


3,919,677 shs

Average Volume

2,567,069 shs

Market Capitalization

$13.58 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Koninklijke Philips?

The following equities research analysts have issued research reports on Koninklijke Philips in the last year: AlphaValue, Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, ING Group, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Oddo Bhf, Societe Generale, StockNews.com, and UBS Group AG.
View the latest analyst ratings for PHG.

What is the current price target for Koninklijke Philips?

7 Wall Street analysts have set twelve-month price targets for Koninklijke Philips in the last year. Their average twelve-month price target is $19.00, suggesting a possible upside of 24.4%. Credit Suisse Group AG has the highest price target set, predicting PHG will reach $31.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $10.90 for Koninklijke Philips in the next year.
View the latest price targets for PHG.

What is the current consensus analyst rating for Koninklijke Philips?

Koninklijke Philips currently has 3 sell ratings, 8 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PHG, but not buy more shares or sell existing shares.
View the latest ratings for PHG.

What other companies compete with Koninklijke Philips?

How do I contact Koninklijke Philips' investor relations team?

Koninklijke Philips' physical mailing address is PHILIPS CENTER AMSTELPLEIN 2, AMSTERDAM P7, 1096 BC. The technology company's listed phone number is (120) 597-7777 and its investor relations email address is [email protected] The official website for Koninklijke Philips is www.philips.com. Learn More about contacing Koninklijke Philips investor relations.